This is unpublished
Moritz Stolla
Association for the Advancement of Blood & Biotherapies (AABB) logo
October 13, 2025

Moritz Stolla is 2025 Hall of Fame Inductee

The AABB Hall of Fame recognizes a prestigious and select group of Foundation grant recipients who leveraged their early-career grant funding into successful careers in transfusion medicine or biotherapies and who demonstrated exemplary leadership
Scroll for more
arrow icon
Back to top
Categories
Faculty Research

The Association for the Advancement of Blood & Biotherapies (AABB) Foundation Board of Directors has selected Dr. Moritz Stolla, associate professor (Hematology and Oncology) as the 2025 inductee for the Hall of Fame.

The Hall of Fame recognizes a prestigious and select group of AABB Foundation grant recipients who leveraged their early-career grant funding into successful careers in transfusion medicine, biotherapies, or patient blood management and who demonstrate exemplary leadership within the field.

Stolla's initial research project in 2018, "Cold-stored Platelets for the Reversal of Dual Antiplatelet Therapy" showed how cold-stored platelets change their function upon transfusion, and that GPVI levels on murine and human platelets decrease compared to RT storage and this leads to reduced responses to collagen and convulxin after transfusion.

“The funding from the AABB Foundation was an incredible help when I started my independent lab," said Stolla. "The AABB foundation award was the first external one I received, a critical step for every junior investigator. Soon, other awards followed, but the AABB award was essential to get launched.”